Future Outlook for Vietnam Pharmaceutical Market
The report titled Vietnam Pharmaceutical Market Outlook To 2022 - by Generic and Patented drugs, by
Prescribed Drugs and OTC Drugs and Therapeutic Drugs (Metabolism and Nutritional Medicine,
Cardiovascular, Central Nervous System, System Infection, Oncology, Musculoskeletal, Respiratory)
provides a comprehensive analysis of Vietnam pharmaceutical market overview and size, growth drivers
and restraints. The report also provides data points on Vietnam Pharmaceutical market by Generic and
Patented drugs, by Prescribed Drugs and OTC Drugs and Therapeutic Drugs (Metabolism and Nutritional
Medicine, Cardiovascular, Central Nervous System, System Infection, Oncology, Musculoskeletal,
Respiratory and Others) along with company profiles of DHG Pharma, Traphaco, Pymepharco, Ha Tey
Pharmaceutical, Mekophar, Domesco, Imexpharma, OPC, Sanofi, GSK, AstraZeneca, Novartis, Roche,
Pfizer, MSD and Bayer. The report also covers government regulations, procedure of how drugs
procured in public hospitals, Comparative Analysis of Pharmaceutical Companies, Trade scenario,
Analyst Recommendations and future outlook for Vietnam Pharmaceutical Market.
Vietnam Pharmaceutical Market Size and Overview